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Abstract
Psychological intervention outcomes depend in part on the therapist who provides
the intervention (a therapist effect). However, recent reviews suggest that therapist
effects may vary as a function of the context in which care is provided and therefore
should not be generalized beyond that context. This study statistically analysed ther-
apist effect differences between care sectors delivering psychological interventions.
The sample comprised routine clinical data from 26,814 patients (69% female; mean
age 38) and 466 therapists in five care sectors: primary care, secondary care, university,
voluntary, and workplace. Therapist effects were analysed using multilevel models and
Markov chain Monte Carlo credible intervals. The therapist effect was significantly
larger in primary care (8.4%) than in any other sector (1.1%–2.3%) except secondary
care (4.1%), after controlling for explanatory baseline and process variables as well as
accounting for differences between clinics. There were no other significant differ-
ences detected between care sectors. These findings support the hypothesis that dif-
ferences in effectiveness between therapists vary depending on the context in which
psychological treatment is provided. Differences in relative therapist impact can vary
by a factor of 4–8 across treatment sectors. This should be considered in the applica-
tion of research evidence, treatment planning, and the design and delivery of psycho-
logical care provision.
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1 | INTRODUCTION
In the psychological intervention literature, therapist effects refer to
systematic variability among therapists regarding patient outcomes,
independent of patient, and treatment characteristics (Barkham, Lutz,
Lambert, & Saxon, 2017). Evidence suggests approximately 5% of var-
iance in outcome is associated with the therapist (Baldwin &
Imel, 2013; Johns, Barkham, Kellett, & Saxon, 2019). Both of these
reviews of therapist effects indicated that study heterogeneity can
impact on the measurement of therapist effects. Johns et al.'s (2019)
recent review drew particular attention to methodological factors
such as study design (randomized controlled trial versus practice-
based study), complexity of outcome measure, use of a reliable and
validated outcome measure, and sufficient sample size. In order to
reduce methodological confounding and derive reliable effects esti-
mates, they recommend that future therapist effects research uses
homogenous, practice-based designs, and multilevel analysis
techniques.
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Regardless of methodology, therapist effects may themselves
vary as a function of care context, such that therapist effects should
be considered only with respect to their specific corresponding care
context. Johns et al. (2019) noted this problem but were unable to
perform statistical comparisons with the data available from the publi-
shed literature.
In the United Kingdom (as in many other countries), psychological
interventions are delivered within a number of different care contexts,
known as sectors. Sectors differ in how they are designed to deliver
care. For example, primary care clinics typically provide brief, front-
line interventions to a wide range of individuals with mild-to-
moderate common mental health conditions. In contrast, secondary
and tertiary sectors provide increasingly specialized and intensive
interventions, to patients who often experience high problem com-
plexity and/or risk of suicide or self-harm. Some sectors serve
populations that may be highly circumscribed or distinct regarding
demographic characteristics. For example, the university counselling
sector will, in the main, offer care to younger, well-educated adults,
and patients accessing the workplace counselling sector will, by defini-
tion, almost all be currently employed, compared with other sectors.
Therapists may have different professional backgrounds, and other
organizational factors can vary, particularly between private and pub-
lic organizations (e.g., workplace policies, salary, and career progres-
sion). These differences at the patient, therapist, treatment, and
organizational level may affect the relative contribution of the thera-
pist to clinical variability. For example, greater patient symptom sever-
ity has been found to be associated with a larger therapist effect
(Saxon & Barkham, 2012). These contextual questions are com-
pounded by a relative lack of research investigating care contexts
other than mainstream care providers (such as treatment provided by
voluntary organizations or universities/colleges).
The current study aimed to use a large data set to address this
question within a single cohesive investigation of therapist effects dif-
ferences across five UK care sectors: primary care, secondary care,
voluntary, university counselling, and workplace counselling. In doing
so, it also sought to address a number of confounding methodological
factors identified by Johns et al. (2019) in previous research—for
example, by using a single statistical approach, a single, reliable, and
well-validated outcome measure, and consistent case-mix variables, as
well as controlling for clinic effects (Firth, Saxon, Stiles, &
Barkham, 2019). Investigating variability in therapist effects contrib-
utes to addressing the question of why we observe differences in
effectiveness between therapists and may thereby suggest how out-
comes may potentially be improved.
2 | METHOD
2.1 | Measures
The primary outcome measure was the patient's post-therapy score
on the Clinical Outcomes in Routine Evaluation-Outcome Measure
(CORE-OM; Evans et al., 2002), a 34-item measure of psychological
distress comprising wellbeing, symptom severity, functioning, and
risk subscales. Risk in this case refers to the patient's day-to-day
risk to self and risk to others. Scores range from 0 to 40, with
higher scores indicating greater distress. Scores above 10 indicate
clinical distress (Connell et al., 2007). A valid CORE-OM score
requires scores on at least 31 of 34 items (90% of items com-
pleted). Psychometric properties demonstrated (Barkham
et al., 2010) include internal consistency of α = 0.93–0.95
(Barkham, Gilbert, Connell, Marshall, & Twigg, 2005), test–retest
reliability of .88 (with outpatients at 1-month intervals; Barkham,
Mullin, Leach, Stiles, & Lucock, 2007), and strong convergent valid-
ity (Cahill et al., 2006; Connell et al., 2007). The CORE-OM was
completed by patients as part of routine practice.
Control variables were also part of the standard CORE data set,
collected as part of routine practice using the CORE Assessment form.
Control variables included were as follows: pre-therapy CORE-OM
nonrisk severity and risk severity scores, patient age and employment
status (employed, other role, and not employed), number of sessions
attended and percentage of offered sessions attended, therapy fre-
quency (more than weekly, weekly, less than weekly, and no fixed fre-
quency), and a variable for clinics.
Pre-intervention patient severity is one of the strongest predic-
tors of patient outcome, as have been found to be associated with
therapist effect size (Bohart & Greaves Wade, 2013; Hamilton &
Dobson, 2002; Saxon & Barkham, 2012). Patients' CORE-OM
scores can be split into risk (to self and others) scores and nonrisk
(e.g., wellbeing, symptoms, and functioning) scores. This was
applied in the current study, given previous research finding that
CORE-OM nonrisk scores were associated with therapist effect
size (Saxon & Barkham, 2012), whereas risk scores predicted
patient outcome but were not associated with the size of therapist
effect. Both of these scores were transformed to range from 0 to
40, for consistency.
Key Practitioner Message
• Psychological intervention outcomes vary according to
the therapist providing the intervention (a therapist
effect).
• Therapist allocation appears to be more important for
outcome in some types of care context compared with
others. Therapist effects cannot be assumed to be univer-
sally applicable.
• Therapist effects were 4–8 times greater in primary care,
compared with university, voluntary, and workplace
settings.
• The context-specific nature of therapist effects and
therefore the variable association between therapist and
patient outcome should be considered in psychological
care planning and delivery.
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Patient age and employment status, and attendance of sessions
also typically predict patient outcome. The number of sessions
attended, attendance rate, and therapy frequency was also included in
order to control for expected variation between sectors in care provi-
sion. For example, patients in voluntary sector and secondary care
clinics have been found to attend an average of 13–16 sessions, com-
pared with primary care, university, and workplace sector who
attended an average of 6–7 sessions. As in many routine clinical data
sets, there were unfortunately no therapist characteristics available
for analysis.
2.2 | Sample
The CORE National Research Database 2011 (Stiles, Barkham, &
Wheeler, 2015) provided the sample pool for this study. The database
comprises routine clinical data from n = 104,474 patients seen by 2,442
therapists across 52 clinics in seven sectors across the United Kingdom.
Sectors were as follows: primary care, secondary care, tertiary care, uni-
versity counselling, workplace counselling, voluntary, and private prac-
tice. Ethical approval was covered by National Research Ethics Service
Application No. 05/Q1206/128 (Amendment 3).
The primary care sector is usually the first point of contact for
people experiencing common mental health problems. Primary care
services include general practitioner (GP) surgeries, community cen-
tres, and Improving Access to Psychological Therapies (IAPTs) pro-
gramme sites. The database used in the current study did not include
IAPT sites, however, due to differences in outcome recording
procedures.
Secondary care services are generally more specialized and treat
more complex or severe mental health difficulties. Secondary care ser-
vices can typically only be accessed via referral from another primary
or secondary care service. Tertiary care services are even more spe-
cialized again. Alternatively, patients can access treatment via univer-
sity or workplace counselling centres, voluntary
organizations/charities, or through private care organizations.
Inclusion criteria for Patients were (i) aged 16–95, (ii) received
individual therapy, (iii) had recorded employment and session atten-
dance data, and (iv) had valid pre-therapy and post-therapy CORE-
OM scores (≥90% items completed). Further analysis-specific inclu-
sion criteria were then applied in order to ensure cluster sizes were
robust (Schiefele et al., 2017), requiring that (i) each therapist had
seen ≥10 patients and (ii) each sector had ≥10 eligible therapists
(Figure 1).
The included sample comprised routine clinical data from
N = 26,814 patients, seen by 466 therapists, across 40 clinics with
numbers in each sector as follows: primary (9,106 patients, 102 thera-
pists, and 5 clinics), secondary (995 patients, 27 therapists, and
6 clinics), university (5,472 patients, 75 therapists, and 10 clinics), vol-
untary (4,794 patients, 171 therapists, and 12 clinics), and workplace
(6,447 patients, 91 therapists, and 7 clinics). Data from private
(N = 287) and tertiary (N = 62) sectors were excluded by the final
inclusion criterion.
Therapists saw a mean of 57.5 patients each (standard deviation
[SD] = 68.8). Clinics had a mean of 11.7 therapists each (SD = 12.6),
whereas sectors had a mean of 93.2 therapists each (SD = 52.1).
Mean age for the sample was 38.2, with 69% female patients.
According to the CORE-OM clinical threshold, 89% of patients met
criteria for clinical distress.
Included patients (compared with patients excluded due to exclu-
sion criteria) were more likely to be female, white, older, and
employed, with lower pre-therapy and post-therapy CORE-OM
scores. Included patients on average attended more sessions, had
higher attendance, less frequent sessions, and were more likely to
have a planned ending (all Bonferroni adjusted p ≤ .004; Table 1).
2.3 | Analysis
Multilevel modelling (MLM) accounts for the hierarchical dependence
inherent in provision of psychological interventions (i.e., each thera-
pist working with multiple patients). MLM simultaneously models vari-
ance at all levels of the hierarchy (Raudenbush & Bryk, 2002),
including random effects (Martindale, 1978).
Multilevel models used a two-stage estimation process, involving
iterative generalized least squares (IGLS) estimation followed by Mar-
kov chain Monte Carlo (MCMC) estimation (Browne, 2016; Rasbash,
Steele, Browne, & Goldstein, 2012). IGLS estimation is efficient to run
and uses relatively automated procedures. As such, it is a common
first-stage estimation approach. MCMC requires more time-
consuming calculations and prior distributions to be input but is able
to calculate Bayesian credible intervals for coefficients that can be
robustly statistically compared. For this reason, it was employed as a
second-stage estimation approach, using prior distributions generated
by the IGLS estimation.
Multilevel models with two levels (patient and therapist) were
developed for each sector. As such, the study used data from one
sample, split into five subsamples, one for each sector. MLM requires
sufficient cluster sizes at each level to allow robust and accurate esti-
mation. Small cluster sizes (particularly at the top level) can lead to
problems including negative bias in standard errors (Maas &
Hox, 2004). A minimum of 50 top level clusters has been rec-
ommended by some (Maas & Hox, 2004), although resilient methods
such as MCMC estimation exist to enable the analysis of smaller sam-
ples (McNeish & Stapleton, 2016). In this case, there were considered
to be insufficient sectors (five) to be able to use sector as a clustering
level. The use of a separate model for each sector also permits easily
interpretable comparison of therapist effects between sectors and
was therefore also a design choice. Again, although the potential for
three-level models was explored, within these subsamples, there were
too few clinics (average eight per sector) to achieve stable models
including clinics as a separate level. As such, clinics were modelled as
fixed effects in the models (i.e., using a categorical variable to repre-
sent the clinic).
The therapist effect was defined as the proportion of overall
unexplained variance in clinical outcome attributable to the therapist
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level (the variance partition coefficient [VPC]). MCMC estimation was
used to calculate 95% credible intervals. Multilevel models (like most
analyses) make statistical assumptions, including that residuals are
homoscedastic and normally distributed. In order to meet these
assumptions, level 1 outcome variance was modelled as a function of
nonrisk severity.
The significance of each control variable, interaction, and random
effect was determined in two ways. First, the reduction in −2*log-
likelihood score (indicating model fit) was required to exceed the
corresponding chi-square critical value. Second, the Z score of the
coefficient was also required to exceed the critical value for 95% con-
fidence (1.96).
Models were tested in the following order. First, random inter-
cepts were tested in a null model. Second, control variables were each
tested. Where control variables were significant using linear coeffi-
cients, polynomial terms were also tested to assess whether they sig-
nificantly improved model fit. Third, random slopes were tested for
each significant control variable. Fourth, interactions between signifi-
cant control variables were tested.
Continuous variables were patient post-therapy severity score,
pre-therapy nonrisk score, pre-therapy risk score, age, number of ses-
sions attended, and percentage of sessions attended. Categorical vari-
ables were patient employment status (employed, other role, and not
employed), therapy frequency (more than weekly, weekly, less than
weekly, and no fixed frequency), and clinic (each clinic was coded as a
separate category).
Employment status categories were derived using Wald tests and
inspection of coefficients before the main analysis from a broader
range of initial categories: not employed (comprising receiving benefits,
unemployed, and retired), other role (comprising part-time student, full-
time student, houseperson, other, and N/A), and employed (comprising
part-time employment and full-time employment).
Wald tests were used within the main model analyses to compare
categories and combine those whose coefficients did not differ
F IGURE 1 Inclusion flowchart.
CORE-OM, Clinical Outcomes in Routine
Evaluation-Outcome Measure; MLM,
multilevel modelling [Colour figure can be
viewed at wileyonlinelibrary.com]
4 FIRTH ET AL.
significantly from each other. Data were analysed using IBM SPSS
Statistics and MLwiN (Rasbash, Charlton, Browne, Healy, &
Cameron, 2016).
3 | RESULTS
3.1 | Multilevel models
Descriptive demographic statistics across sectors is shown in Table 2.
Summary multilevel model specifications are shown in Table 3 (full
specifications are included in the supporting information). Significant
random intercepts were detected in all five sectors, indicating the
presence of therapist effects. Nonrisk severity, risk-related severity,
sessions attended, and clinic attended were significant in all sectors.
Nonrisk severity and risk-related severity were associated with poorer
outcome. Attending more sessions was also associated with poorer
outcome in all but the voluntary sector. In contrast, percentage of ses-
sions attended was significant in all but the secondary care sector,
and was consistently associated with more positive outcome. Age was
significant in all but the university sector, such that older patients,
experienced poorer outcome. Employment status was significant in all
but the university and workplace sectors - being employed were asso-
ciated with the most positive outcomes, followed by patients in other
roles, with patients who were not employed experiencing poorest
outcomes. Therapy frequency was not significant in any sector. A
number of polynomial coefficients and interactions were detected (full
model specifications available as supporting information). A number of
TABLE 1 Comparisons between included and excluded patients
Variable Included sample Excluded patient Included/Excluded difference
Patients 26,814 77,660
Mean patients per therapist (SD) 57.5 (68.8)
Mean therapists per clinic (SD) 11.7 (12.6)
Mean patient age (SD) 38.2 (13.0) 34.9 (13.2)a t(99,309) = 35.0, p < .001
Female 69% 66%b χ2(1,N = 103,082) = 82.39, p < .001
White 88%c 81%d χ2(1,N = 92,544) = 599.353, p < .001
Employment status
In work 58% 41%e χ2(2,N = 100,084) = 2411.022, p < .001
Other role 27% 41%e
Not employed 14% 18%e
Mean pre-therapy CORE (SD) 17.9 (6.3) 18.2 (6.8)f t(55,870.287) = −7.48, p < .001
Mean pre-therapy nonrisk CORE (SD) 20.9 (6.9) 21.2 (7.4)g t(54,611.427) = −5.75, p < .001
Mean pre-therapy risk CORE (SD) 3.9 (5.7) 4.8 (6.6)h t(59,210.991) = −20.86, p < .001
Mean post-therapy CORE (SD) 8.9 (6.4) 9.6 (6.9)i t(18,105.580) = −9.48, p < .001
Mean therapy sessions (SD) 8.3 (9.4) 7.6 (13.7)j t(62378.481) = 7.24, p < .001
Mean session attendance % (SD) 90% (16%) 76% (26%)j t(60,064.939) = 82.485, p < .001
Therapy frequency
More than weekly 1% 1%k
Weekly 56% 64%k χ2(3,N = 55,114) = 684.423, p < .001
Less than weekly 30% 21%k
No fixed frequency 14% 14%k
Planned ending % 92%l 50%m χ2(1,N = 63,543) = 12656.671, p < .001
Abbreviations: CORE, Clinical Outcomes in Routine Evaluation; SD, standard deviation.
aN = 72,497.
bN = 76,268.
cN = 26,240.
dN = 66,304.
eN = 73,270.
fN = 59,101.
gN = 61,230.
hN = 61,150.
iN = 10,553.
jN = 35,970.
kN = 28,300.
lN = 26,717.
mN = 36,826.
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interactions were detected, most notably involving pre-therapy
severity, attendance percentage, and sessions attended.
3.2 | Therapist effects
MCMC-estimated therapist effects after controlling for variables and
clinics were as follows (95% credible intervals in parentheses): primary
care = 8.4% (5.8%–11.7%), secondary care = 4.1% (0.9%–9.3%), uni-
versity = 2.1% (1.1%–3.7%), voluntary = 2.3% (0.4%–2.2%), and work-
place = 1.1% (0.4%–2.2%). These results are shown in Figure 2.
Directly comparing overlap between credible intervals can pro-
duce conservatively biased assessments of significance. As such, 95%
credible intervals for the between-sector difference in MCMC-
estimated therapist effect chains were used to compare the primary
care sector with each other sector. The primary care therapist effect
TABLE 2 Comparison of intake characteristics between sectors
Variable Primary care Secondary care University Voluntary Workplace
Patients 9,106 995 5,472 4,794 6,447
Mean patient age (SD) 42.0 (13.6) 41.4 (13.4) 26.2 (8.7) 38.2 (10.8) 42.5 (10.2)
Employment statusa
In work (%) 59 42 11 63 96
Other role (%) 17 11 88 13 3
Not employed (%) 24 47 1 24 1
Mean pre-therapy CORE (SD) 18.4 (6.2) 20.6 (7.0) 17.6 (6.1) 17.3 (6.5) 17.3 (6.1)
Mean pre-therapy nonrisk CORE (SD) 21.5 (6.8) 23.4 (7.3) 20.5 (6.7) 20.1 (7.2) 20.4 (6.8)
Mean pre-therapy risk CORE (SD) 4.1 (5.8) 7.6 (8.0) 3.9 (5.6) 4.2 (5.7) 2.8 (4.7)
Abbreviations: CORE, Clinical Outcomes in Routine Evaluation; SD, standard deviation.
aEmployment status categories defined as follows: employed (part-time employment and full-time employment), not employed (receiving benefits, unem-
ployed, and retired), and other role (part-time student, N/A, houseperson, full-time student, and other).
TABLE 3 Summary multilevel model specifications by sector
Specification Primary Secondary University Voluntary Workplace
Constant 9.723R_ 13.541R_ 8.935R_ 9.784R_ 7.979R_X
Nonrisk severity (polynomial 2 term) 0.328RX 0.461X_ 0.302X_ 0.309X_ 0.268X_
—
RX
—
RX
—
RX 0.003__ —RX
Risk severity (polynomial 2 term) 0.104__ 0.132__ 0.108RX 0.165RX 0.222__
—
RX 0.009__ —RX —RX −0.007__
Age (polynomial 2 term) 0.029X_ 0.024__ -RX 0.027X_ 0.028X_
—
RX
—
RX
—
RX
—
RX 0.001__
Employed −1.400__ −1.073__ —RX −1.377__ —RX
Other role −0.817__ Reference__ —RX −0.626__ —RX
Not employed Reference__ Reference__ —RX Reference__ —RX
Sessions (polynomial 2 term) 0.184R_ 0.043X_ 0.049X_ −0.033__ 0.108R_
0.001RX —RX —RX 0.0003__ −0.001__
Attendance (polynomial 2 term) −0.033X_ —RX −0.033X_ −0.017RX −0.027__
—__ —RX —RX —RX −0.0003_
Patients 9,106 995 5,472 4,794 6,447
Therapists 102 27 75 171 91
Clinics 5 6 10 12 7
Mean patients per therapist (SD) 89.3 (90.7) 36.9 (27.9) 73.0 (60.5) 28.0 (29.5) 70.8 (84.1)
Mean therapists per clinic (SD) 20.4 (15.8) 4.5 _(4.8) 7.5 _(6.8) 14.3 (18.0) 13.0 _(5.8)
Note. Variable coefficients are for linear effects, unless stated otherwise (polynomial square terms are noted where significant).R denotes significant random
effect, and x denotes significant interaction with another variable.
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(8.4%) was significantly larger than the therapist effect in every other
sector (1.1%–2.3%) except for secondary care (4.1%). There were no
significant differences between the secondary, university, voluntary,
and workplace sectors.
Significant random slopes were detected, indicating that therapist
effects were moderated by measured variables. In the primary care
sector, the therapist effect was larger for patients with higher nonrisk
severity scores. In the university and voluntary sectors, the therapist
effect was larger for patients with higher risk severity scores. In the
primary and workplace sectors, the therapist effect was larger for
patients receiving higher numbers of sessions. Finally, in the voluntary
sector, the therapist effect was larger for patients with fewer missed
sessions.
4 | DISCUSSION
Finding that the therapist effect in the primary care sector was sub-
stantially greater than in the university, voluntary, and workplace sec-
tors (which were comparable with each other) underlines the
importance of considering the context of care in understanding thera-
pist effects. The therapist effect in the secondary care sector was
intermediate, with no significant differences from any other sector. In
the United Kingdom, the National Health Service (NHS) provides the
therapy in both primary care and secondary care sectors but not in
the other sectors. The observed differences did not appear to be
explained by patient intake severity, age, employment status, or con-
sistent attendance. Nor were they explained by treatment duration or
the clinic where patients received treatment. Notably, the non-NHS
sector therapist effects were qualitatively lower than is typically
reported in practice-based studies (Baldwin & Imel, 2013; Johns
et al., 2019). This is consistent with Johns et al.'s (2019) findings of
lower therapist effects in university specific practice-based studies.
It is difficult to do more than speculate about mechanisms under-
lying our findings, particularly given the broad credible intervals for
secondary care. One hypothesis is that therapists in primary care
settings (or in NHS settings more generally) tend to be relatively more
variable in their skill or practice characteristics compared with other
non-NHS care contexts. This is arguably unintuitive, given the NHS is
a national, single parent organization with an embedded system of
standards and policies, compared with the multiple universities, volun-
tary organizations, or workplaces, each with potentially different poli-
cies, funding streams, therapist recruitment practices, codes of
professional practice, and so forth. It may be helpful to examine other
factors that may have contributed to increased therapist variability in
the primary care sector, such as variation in training/experience work-
ing with the relevant population, or the effects of burnout.
A second hypothesis may be that differences in therapist effects
are partially accounted for by differences in patient population or
organizational structure. For example, non-NHS clinics may exhibit
relatively greater heterogeneity in nontherapist factors
(e.g., organizational factors), thereby reducing the relative contribution
of the therapist to outcome. Clinical populations in some care con-
texts may be much more highly selected than in other contexts. In
principle, this might reduce variance at the patient level, thereby
potentially increasing the relative therapist effect. However, statistical
associations may be more complex; for example, a homogenous high-
severity population might be expected to have greater therapist
effects than a population with more heterogeneous (and therefore
lower average) severity (Saxon & Barkham, 2012). Potential organiza-
tional factors include constraints on treatment duration (e.g., imposed
by public funding and political pressures). It has been argued that ther-
apeutic dyads tend to regulate treatment duration to optimize out-
comes (Stiles et al., 2015). If duration is relatively free to vary,
therapists who work less quickly may have longer treatments but simi-
lar mean outcomes, reducing therapist effects. The current study con-
trolled for treatment duration, so this specific factor is less likely to
account for observed differences. However, there may be other con-
tributory organizational factors that were unavailable in the current
study. As such, it is difficult to make specific conclusions from the cur-
rent findings alone.
A third hypothesis is that the differences could reflect undetected
neighbourhood effects (Firth et al., 2019). Therapists in primary care
tend to work in locations more embedded in communities than do
therapists in centralized clinics. Systematic differences in
neighbourhood deprivation (or other neighbourhood/geographic vari-
ables) between therapists' caseloads may impact differentially on ther-
apists' outcomes. Without explicit modelling of a neighbourhood
level, this variance may be inappropriately assigned to the therapist
level. This study did control for clinic effects, but it was not possible
to appropriately model neighbourhood effects (e.g., using a three-level
model), due to sample constraints. Despite this, the study addressed a
number of methodological factors identified by Johns et al. (2019) as
potential confounders. These included using a single practice-based
data set, a single well-supported analytical approach, a single reliable
and validated outcome measure, and sufficient sample size. Because
inclusion criteria required pre- and post-therapy symptom severity
scores and noncompleters rarely completed the post-therapy forms,
patients who did not complete treatment were much less likely to be
F IGURE 2 Therapist effect estimates and 95% credible intervals
for each sector, after controlling for variance at the clinic level
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included. Thus, it cannot be assumed that the findings of the current
study will generalize to patients who do not complete treatment.
The finding that therapist effects may vary according to context
should be considered in research design, clinical application of
research evidence, treatment planning, and psychological care provi-
sion. Analyses should control for relevant sources of variability such
as therapist effects, clinic effects, and neighbourhood effects.
Research cannot be assumed to generalize beyond specific care con-
texts. For example, research findings from a study conducted in a uni-
versity clinic may underestimate the variability between therapists in
other care contexts and therefore overestimate differential treatment
effects in those contexts. Further research and routine evaluation
should be undertaken to understand how therapist effects may vary
in specific clinical delivery contexts (e.g., international/cultural differ-
ences and specific clinical populations).
In clinical practice, a care context with larger therapist effects
might focus more resources on understanding differences in effective-
ness between their therapists; for example, by seeking to
(i) understand potential confounding systematic differences in case-
load or care provision, (ii) improve the outcomes of less effective ther-
apists (e.g., using techniques such as deliberate practice; Chow
et al., 2015), or (iii) systematize what is working well for more effec-
tive therapists. In contrast, a care context with smaller therapist
effects might focus on more generalized initiatives (i.e., those applica-
ble to all therapists) or seek to understand and act on variability in
other parts of the care system (either intraclinic or
interclinic—e.g., standardization of treatment, accessible appoint-
ments, and waiting lists). Very low therapist effects might reflect a lim-
itation or bottleneck in the care system that is preventing therapists
from fully contributing to outcome (e.g., because of very high dropout
rates). Of course, any interpretation of therapist effects or resultant
actions also depend on other clinical information, such as average out-
comes in the service; for example, in the case of low therapist effects,
are therapists consistently enabling recovery, or consistently failing to
achieve clinical change?
5 | CONCLUSIONS
Variance in therapists' outcomes appeared far greater (up to 4–8×) in
NHS primary care than in non-NHS sectors. Estimates of the size of
therapist effects should be understood in relation to the context from
which they were derived rather than general characteristics. This may
have implications in the design and application of research evidence,
treatment planning, and the delivery of psychological care provision.
Differences in state versus private provision, or front-line versus spe-
cialist provision may be useful to explore in future research.
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